Diuretics for respiratory distress syndrome in preterm infants

Audra Stewart1, Luc P Brion, Roger Soll

  • 1Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas, USA, 75390-9063.

Insights

Diuretics like furosemide do not benefit preterm infants with respiratory distress syndrome (RDS) long-term and increase risks. Theophylline also shows no long-term benefits for RDS in preterm infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Lung edema is a common complication of respiratory distress syndrome (RDS) in preterm infants.
  • Diuretic administration is sometimes used to manage fluid overload in these infants.

Purpose of the Study:

  • To evaluate the risks and benefits of using diuretics in preterm infants diagnosed with RDS.
  • To synthesize evidence from randomized controlled trials on diuretic use in neonatal RDS.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) identified through extensive database searches (CENTRAL, MEDLINE, EMBASE) and conference abstracts.
  • Inclusion criteria focused on preterm infants (<5 days old) with RDS, randomly assigned to diuretic treatment, with key outcome measures like mortality, patent ductus arteriosus, and renal function.
  • Data extraction and analysis followed Cochrane Collaboration standards, with independent review by two investigators.

Main Results:

  • Seven studies met the criteria; six evaluated furosemide, predating modern RDS management. Furosemide offered no sustained benefits and increased risks of patent ductus arteriosus and hemodynamic instability.
  • A recent study on theophylline showed no long-term advantages, although it transiently improved renal function and reduced oligoanuria without affecting renal function at discharge.

Conclusions:

  • Current evidence does not support the routine use of furosemide in preterm infants with RDS.
  • The potential risks of furosemide, including hypovolemia and symptomatic patent ductus arteriosus, necessitate careful consideration.
  • Insufficient data exist to recommend routine low-dose theophylline administration for preterm infants with RDS.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...